25.48
price up icon3.79%   0.93
pre-market  プレマーケット:  25.85   0.37   +1.45%
loading
前日終値:
$24.55
開ける:
$26
24時間の取引高:
2.48M
Relative Volume:
2.36
時価総額:
$2.23B
収益:
$23.38M
当期純損益:
$-155.22M
株価収益率:
-11.63
EPS:
-2.19
ネットキャッシュフロー:
$-134.36M
1週間 パフォーマンス:
+2.49%
1か月 パフォーマンス:
+4.99%
6か月 パフォーマンス:
+23.87%
1年 パフォーマンス:
-35.49%
1日の値動き範囲:
Value
$24.18
$26.01
1週間の範囲:
Value
$24.04
$26.01
52週間の値動き範囲:
Value
$13.45
$40.25

Ideaya Biosciences Inc Stock (IDYA) Company Profile

Name
名前
Ideaya Biosciences Inc
Name
セクター
Healthcare (1155)
Name
電話
650-443-6209
Name
住所
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Name
職員
131
Name
Twitter
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
IDYA's Discussions on Twitter

IDYA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IDYA
Ideaya Biosciences Inc
25.48 2.15B 23.38M -155.22M -134.36M -2.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
401.00 100.25B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.90 61.55B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
447.00 58.53B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
706.41 43.59B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
332.04 33.67B 3.81B -644.79M -669.77M -6.24

Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-22 開始されました TD Cowen Buy
2025-07-10 再開されました Goldman Neutral
2025-06-26 開始されました Wells Fargo Overweight
2024-11-18 開始されました Stephens Overweight
2024-11-05 ダウングレード Leerink Partners Outperform → Market Perform
2024-10-24 開始されました UBS Buy
2024-10-15 開始されました Cantor Fitzgerald Overweight
2024-07-08 開始されました Mizuho Outperform
2024-03-08 開始されました BTIG Research Buy
2023-08-08 開始されました SVB Securities Outperform
2023-05-24 開始されました Goldman Buy
2023-04-24 アップグレード Stifel Hold → Buy
2023-03-23 開始されました Berenberg Buy
2023-02-28 開始されました RBC Capital Mkts Outperform
2022-12-28 開始されました CapitalOne Overweight
2022-10-27 開始されました Citigroup Buy
2022-08-15 ダウングレード Stifel Buy → Hold
2022-07-18 再開されました Oppenheimer Outperform
2022-03-10 アップグレード Stifel Hold → Buy
2021-09-23 開始されました Stifel Hold
2021-06-04 再開されました Robert W. Baird Outperform
2021-03-11 開始されました Guggenheim Buy
2020-10-07 開始されました Wedbush Outperform
2020-09-01 開始されました Northland Capital Outperform
2020-07-13 アップグレード JP Morgan Neutral → Overweight
2020-06-17 繰り返されました H.C. Wainwright Buy
2020-04-06 開始されました H.C. Wainwright Buy
2020-03-13 開始されました ROTH Capital Buy
2019-10-17 開始されました Oppenheimer Outperform
2019-09-10 開始されました Robert W. Baird Outperform
2019-06-17 開始されました Citigroup Buy
2019-06-17 開始されました JP Morgan Neutral
2019-06-17 開始されました Jefferies Buy
すべてを表示

Ideaya Biosciences Inc (IDYA) 最新ニュース

pulisher
07:03 AM

IDEAYA Biosciences submits IND for new cancer drug IDE892 - Investing.com

07:03 AM
pulisher
06:00 AM

Novel PRMT5 Inhibitor Targets 15-20% of Lung Cancer Patients: IDEAYA's IDE892 Advances to Clinical Stage - Stock Titan

06:00 AM
pulisher
05:54 AM

How to escape a deep drawdown in IDEAYA Biosciences Inc.July 2025 Closing Moves & Weekly High Return Forecasts - Newser

05:54 AM
pulisher
05:46 AM

Is IDEAYA Biosciences Inc. a cyclical or defensive stock2025 Valuation Update & Safe Entry Zone Tips - خودرو بانک

05:46 AM
pulisher
04:35 AM

Will IDEAYA Biosciences Inc. continue its uptrend2025 EndofYear Setup & Proven Capital Preservation Methods - Newser

04:35 AM
pulisher
04:30 AM

Why IDEAYA Biosciences Inc. stock attracts strong analyst attentionWeekly Profit Summary & Risk Managed Investment Entry Signals - Newser

04:30 AM
pulisher
03:32 AM

Comparing IDEAYA Biosciences Inc. in custom built stock radars2025 Institutional Moves & Short-Term Trading Alerts - Newser

03:32 AM
pulisher
03:21 AM

Will IDEAYA Biosciences Inc. stock recover after recent drop2025 Analyst Calls & Reliable Trade Execution Plans - Newser

03:21 AM
pulisher
02:57 AM

What high frequency data says about IDEAYA Biosciences Inc.Earnings Trend Report & Daily Technical Stock Forecast Reports - Newser

02:57 AM
pulisher
Sep 02, 2025

Regression analysis insights on IDEAYA Biosciences Inc. performance2025 Macro Impact & Safe Entry Momentum Stock Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is IDEAYA Biosciences Inc. gaining market share2025 Trading Recap & Technical Analysis for Trade Confirmation - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

In Brief: Servier, IDEAYA Partner On Darovasertib For Uveal Melanoma - insights.citeline.com

Sep 02, 2025
pulisher
Sep 02, 2025

Trend analysis for IDEAYA Biosciences Inc. this week2025 Major Catalysts & Weekly Sector Rotation Insights - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Volatility clustering patterns for IDEAYA Biosciences Inc.2025 Fundamental Recap & AI Powered Trade Plan Recommendations - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How to recover losses in IDEAYA Biosciences Inc. stockMarket Growth Review & Weekly Watchlist for Hot Stocks - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will IDEAYA Biosciences Inc. benefit from geopolitical trendsRate Cut & Weekly Consistent Profit Watchlists - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Servier pays big for ex-US darovasertib rights - The Pharma Letter

Sep 02, 2025
pulisher
Sep 02, 2025

How high can IDEAYA Biosciences Inc. stock go2025 Dividend Review & Real-Time Volume Analysis Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Servier pays $200M upfront to Ideaya; Zymeworks ends work on T cell engager - Endpoints News

Sep 02, 2025
pulisher
Sep 02, 2025

Can IDEAYA Biosciences Inc. rally from current levelsStop Loss & Fast Momentum Entry Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Ideaya Biosciences Shares Jump Following $210 Million Licensing Deal with Servier - MSN

Sep 02, 2025
pulisher
Sep 02, 2025

The Oncology Institute, Inc. shares fall 1.18% intraday as IDEAYA Biosciences announces positive trial data for darovasertib and crizotinib combination. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

IDEAYA Biosciences and Servier in-pact to develop eye cancer treatment - Seeking Alpha

Sep 02, 2025
pulisher
Sep 02, 2025

Ideaya Biosciences stock surges after $210 million licensing deal with Servier - Investing.com

Sep 02, 2025
pulisher
Sep 02, 2025

Precision Biosciences shares fall 1.22% premarket after IDEAYA Biosciences' partnership with Servier. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Is this a good reentry point in IDEAYA Biosciences Inc.Inflation Watch & Weekly Top Stock Performers List - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

IDEAYA Biosciences' Strategic Licensing of Darovasertib: A Catalyst for Sustainable Growth and Value Creation - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

IDEAYA Biosciences, Inc. Enters into License Agreement with Les Laboratoires Servier - MarketScreener

Sep 02, 2025
pulisher
Sep 02, 2025

Analyzing drawdowns of IDEAYA Biosciences Inc. with statistical tools2025 Historical Comparison & Risk Controlled Stock Pick Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

IDEAYA Biosciences Soars 10.63% on Servier Partnership for Uveal Melanoma Treatment - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

IDEAYA Biosciences Licenses Darovasertib to Servier - TipRanks

Sep 02, 2025
pulisher
Sep 02, 2025

Real time breakdown of IDEAYA Biosciences Inc. stock performance2025 Retail Activity & Daily Profit Focused Stock Screening - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

IDEAYA Biosciences receives $210mln upfront for darovasertib license, up to $320mln in milestones. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide - WV News

Sep 02, 2025
pulisher
Sep 02, 2025

What data driven models say about IDEAYA Biosciences Inc.’s future2025 AllTime Highs & Verified Momentum Stock Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is It Too Late to Sell IDEAYA Biosciences Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr

Sep 02, 2025
pulisher
Sep 01, 2025

Is IDEAYA Biosciences Inc. a momentum stock2025 Price Momentum & AI Powered Market Trend Analysis - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Risk adjusted return profile for IDEAYA Biosciences Inc. analyzedJuly 2025 Action & High Accuracy Swing Entry Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Can IDEAYA Biosciences Inc. expand into new marketsWeekly Trade Report & Weekly Stock Performance Updates - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Backtesting results for IDEAYA Biosciences Inc. trading strategies2025 Top Decliners & AI Powered Trade Plan Recommendations - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

IDEAYA Biosciences Inc. Reversal Rally May Surprise Bears getLinesFromResByArray error: size == 0 - thegnnews.com

Sep 01, 2025
pulisher
Aug 31, 2025

Measuring IDEAYA Biosciences Inc.’s beta against major indicesMarket Activity Report & Free Daily Entry Point Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Chart based analysis of IDEAYA Biosciences Inc. trendsQuarterly Portfolio Summary & Community Consensus Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Can IDEAYA Biosciences Inc. Outperform Peers After Recent Pullback getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 31, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-31 12:35:43 - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

IDEAYA Biosciences Inc. stock daily chart insightsPortfolio Risk Summary & Real-Time Market Trend Scan - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Analyzing net buyer seller activity in IDEAYA Biosciences Inc.Weekly Gains Summary & Daily Chart Pattern Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Analyzing IDEAYA Biosciences Inc. with risk reward ratio chartsJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Real time scanner hits for IDEAYA Biosciences Inc. explainedTrade Exit Report & Weekly Stock Breakout Alerts - Newser

Aug 31, 2025

Ideaya Biosciences Inc (IDYA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$25.89
price up icon 4.10%
$85.98
price up icon 1.62%
$23.84
price up icon 0.59%
$100.62
price up icon 0.62%
$145.30
price up icon 6.76%
biotechnology ONC
$332.04
price up icon 8.49%
大文字化:     |  ボリューム (24 時間):